Clinical and Basic Investigations Into Congenital Disorders of Glycosylation
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeNot listed
SponsorIcahn School of Medicine at Mount Sinai
About this trial
The purpose of this research is to study the natural history of congenital disorders of glycosylation and its causes and treatments.
Eligibility criteria
Qualifiers
Individuals with a genetically, enzymatically, or molecularly confirmed diagnosis of CDG or NGLY1 deficiency
Disqualifiers
None
Trial design
Treatments tested in this trial
- Not listed
Trial groups
No trial groups listed
Sponsors and collaborators
Icahn School of Medicine at Mount Sinai
Lead sponsor
National Institute of Neurological Disorders and Stroke (NINDS)
Collaborator
Seattle Children's Hospital
Collaborator
Children's Hospital of Philadelphia
Collaborator
University of Pittsburgh
Collaborator
Boston Children's Hospital
Collaborator
Tulane University School of Medicine
Collaborator
Baylor College of Medicine
Collaborator
University of Minnesota
Collaborator
Children's Hospital Colorado
Collaborator
Sanford-Burnham Medical Research Institute
Collaborator
University of Utah
Collaborator
University of Alabama at Birmingham
Collaborator
Mayo Clinic
Collaborator
Source ClinicalTrials.gov